09.06.2013 Views

9. Treatment of Amatoxin Poisoning-20 year retrospective analysis

9. Treatment of Amatoxin Poisoning-20 year retrospective analysis

9. Treatment of Amatoxin Poisoning-20 year retrospective analysis

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

736<br />

time between appearance <strong>of</strong> jaundice and onset <strong>of</strong><br />

encephalopathy, and bilirubin concentration. The criteria<br />

have been recently evaluated by the University <strong>of</strong><br />

Pittsburgh for 177 patients over a 13-<strong>year</strong> period and<br />

were found to be relatively effective in predicting death<br />

and the need for transplantation. [406] French emergency<br />

liver units rely on the combination <strong>of</strong> encephalopathy<br />

stages (III and IV) with factor V concentration and<br />

age. [407 – 409] Other prognostic models reviewed by Mas<br />

and Rodés [244] based on hemodynamic disturbances and<br />

clinical course <strong>of</strong> FHF have also been developed.<br />

Furthermore, other variables such as a factor VIII/V<br />

ratio [410] as well as serial a-fetoprotein levels [245] might<br />

be useful tests for predicting survival in FHF. Lastly, a<br />

Gc level ,34 mg/mL 48 hours after admission strongly<br />

suggests a stage <strong>of</strong> liver failure beyond which recovery<br />

will not occur. [411]<br />

Despite the lack <strong>of</strong> absolute predictors, prognostic<br />

factors such as stage <strong>of</strong> encephalopathy, coagulation<br />

tests, metabolic abnormalities, and age are useful in the<br />

rational planning <strong>of</strong> LT. Of 31 transplanted patients<br />

having undertaken OLT (including 4 children below 10<br />

<strong>year</strong>s <strong>of</strong> age), the prognostic factors used for 27 cases are<br />

listed in Table 7.<br />

Encephalopathy Stages<br />

The association between encephalopathy stages<br />

(I–IV) [412] and vital prognosis is controversial. According<br />

to Bernuau et al. [413] and Frohburg et al., [399]<br />

encephalopathy does not always reflect liver function<br />

deterioration. Since advanced encephalopathy typically<br />

occurs late in the course <strong>of</strong> the FHF, the stage <strong>of</strong><br />

encephalopathy may be <strong>of</strong> limited use. [403] Other authors<br />

promote encephalopathy stage as the most powerful<br />

clinical indicator <strong>of</strong> the severity <strong>of</strong> liver disease.<br />

[244,409,414,415] According to Gill and Sterling, [245]<br />

patients with a stage II encephalopathy have a mortality<br />

<strong>of</strong> 30% while those who progress to stage IV have a<br />

mortality rate greater than 80%. In the early use <strong>of</strong> OLT<br />

for amatoxin poisoning, encephalopathy stages (III and<br />

IV) were the major decision factors for this surgery.<br />

[80,103,106,136,154,193,199]<br />

However, Klein’s experience [102] indicated a clinical<br />

course <strong>of</strong> amatoxin poisoning characterized by slow<br />

deterioration over a week that then worsens quickly. This<br />

pattern may lead to an early underestimation <strong>of</strong> liver<br />

damage. Consequently, several authors think that LT<br />

should be considered with the onset <strong>of</strong> mild encephalopathy<br />

(stages I and II) before the onset <strong>of</strong> progressive and<br />

MARCEL DEKKER, INC. 270 MADISON AVENUE NEW YORK, NY 10016<br />

©<strong>20</strong>02 Marcel Dekker, Inc. All rights reserved. This material may not be used or reproduced in any form without the express written permission <strong>of</strong> Marcel Dekker, Inc.<br />

pr<strong>of</strong>ound neurological signs resulting from severe<br />

amatoxin intoxication [86,156,198,199] (Table 7).<br />

Coagulation Factors<br />

No definitive conclusion can be drawn about the<br />

usefulness <strong>of</strong> the degree <strong>of</strong> coagulopathy as an indication<br />

for LT because too few patients are included in clinical<br />

data, and prophylactic administration <strong>of</strong> fresh frozen<br />

plasma modifies or prevents interpretation <strong>of</strong> coagulation<br />

factors. [401] The PT is considered the most satisfactory<br />

test <strong>of</strong> hepatocellular necrosis and prognosis. [405,414,415]<br />

Some authors suggest that factor V level is more sensitive<br />

and reliable than PT and a better indicator <strong>of</strong> recovery<br />

than other biological factors. [158,407,416,417] According to<br />

Izumi et al., [418] the predictive accuracy <strong>of</strong> plasma factor<br />

V is less than that <strong>of</strong> international normalized result<br />

(INR) as advocated by Harrison et al. [419] A factor VIII/V<br />

ratio <strong>of</strong> more than 30% can be associated with a poor<br />

prognosis. [410] The dynamics <strong>of</strong> a biological marker<br />

could be <strong>of</strong> greater predictive value than the minimum or<br />

maximum level <strong>of</strong> the variable itself. The progressive<br />

prolongation <strong>of</strong> PT was noted as an outcome predictor <strong>of</strong><br />

the patients with FHF and its evolution over 4 days after<br />

the poisonous mushroom meal was suggested as a<br />

reliable indicator <strong>of</strong> recovery or death. [14]<br />

Metabolic Abnormalities<br />

Enjalbert et al.<br />

Metabolic abnormalities such as lactic acidosis,<br />

hypoglycemia, hyperbilirubinemia, and increased aminotransferases<br />

seen in FHF may also provide foundation<br />

for LT decisions. [244] Lactic acidosis and hypoglycemia<br />

are cited as prognostic factors associated with encephalopathy<br />

stage II and prolonged PT that determine urgent<br />

LT. [99,151,156,199] Several studies have shown that a high<br />

level <strong>of</strong> bilirubin (.300 mmol/L) is a sign <strong>of</strong> fatal<br />

prognosis. [399,405,4<strong>20</strong>] On the basis <strong>of</strong> their own<br />

experience, Faulstich and Zilker [14] suggested that LT<br />

be performed when an amatoxin poisoned patient<br />

exhibits a PT below <strong>20</strong>% associated with both high<br />

bilirubin and creatinine (.5 and .2 mg/dL, respectively),<br />

on day 3. Patients with progressive failure have<br />

continued rise in the bilirubin and prolongation <strong>of</strong> PT<br />

despite declining aminotransferases. [245] Recent results<br />

support the hypothesis that a sustained elevation in<br />

markers <strong>of</strong> regeneration (a-fetoprotein, g-glutamyl<br />

transferase) for more than 10–12 hours combined with<br />

a similarly maintained decline in markers <strong>of</strong> necrosis<br />

(ASAT, ALAT, alkaline phosphatase, LDH) levels could<br />

aid in prediction <strong>of</strong> recovery. [124]

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!